All News

Why the market is expecting such significant growth (and how pharmacists can keep their patients in the huge market).

Pharmacists must find good alternative therapeutic substitutions for sodium nitroprusside in the face of price gouging and drug shortages.

Following checklists may not be what you think of when you think of the job of someone in a profession.

There is lots of room for both success and failure in the Alzheimer's drug market.

Interventions by pharmacists can help improve the results of diabetes clinical trials.

Good glucose control can help children and teens with type 1 diabetes boost their quality of life.

The first opioid taken off the shelves because of potential abuse.

A study found that pharmacy practice faculty experience high rates of emotional exhaustion.

NACDS and APhA warn that letting Americans buy foreign drugs could be disastrous.

Increased collaboration with physicians means better health outcomes, but what does that look like in the real world?

Reimbursement, initiation, and what pharmacists can do.

In a letter to the CMS, DIR fees take precedence

The PBM giant claims it is owed $14.5 million in fees.

Gottlieb and the FDA are being praised for their efforts, but could they be doing more?

Law curbs pharmacist hours to prevent errors due to fatigue.

Pembrolizumab gets FDA approval for cancers with a certain biomarker.

Former NASA astronaut to keynote event helping pharmacists explore some of the biggest challenges facing pharmacy.

As stocks of the vital drug become rarer, pharmacists could be the ones combatting the shortage.

The popular PDUFA for the FDA is up for its five-year reauthorization.

New product uses new technology to break down earwax

New drugs projected to be major blockbuster drugs by 2021.

Easy-to-swallow bits of news from around the world of pharmacy.

The worst of the worst customers that our readers have had the (dis)pleasure of helping.

Are PBMs responsible for higher drug prices or is something else to blame?

Amazon has massive resources, but it may struggle to enter the PBM marketplace.

Study shows that anti-detailing policies can increase generic prescribing.

Generic drug prevents post-birth bleeding deaths

Studies have linked type 2 diabetes drug to increased risk of foot and leg amputations.